1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Washington University in St. Louis, St. Louis Children’s Hospital, St. Louis, MO.
2Pediatric Cardiac Care Center, University of Rochester, Golisano Children’s Hospital, Rochester, NY.
3Paediatric Intensive Care, University of Cape Town and Red Cross War Memorial Children’s Hospital, Cape Town, South Africa.
4Richard C. Reynolds Chair of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ.
5Division of Pediatric Critical Care, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA.
6Division Chief of Pediatric Critical Care Medicine, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA.
7Division of Pediatric Critical Care, Department of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montréal, QC, Canada.
8Division of Pediatric Critical Care, Department of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montréal, QC, Canada.
Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI) members are listed in Appendix 1.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/pccmjournal).
The Transfusion and Anemia Expertise Initiative was supported, in part, by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute under award number 1 R13 HD088086-01, the Society for the Advancement of Blood Management (SABM)-Haemonetics Research Starter Grant, the CHU-Sainte-Justine Foundation, the Washington University Children’s Discovery Institute (CDI-E1-2015–499), and the University of Massachusetts Medical School.
Drs. Doctor, Carson, Valentine, and Bateman received support for article research from the National Institutes of Health (NIH). Dr. Doctor’s institution received funding from the NIH, the Department of Defense, and KaloCyte. Dr. Argent received funding from the Transfusion and Anemia Expertise Initiative group that coordinated the preparation of these documents (provided funding for travel to and accommodation in Montreal for a meeting regarding the documents), N. Kelly Attorneys, and he has received financial support for travel, accommodation, and conference fees from a number of national and international conferences. Dr. Carson’s institution received funding from Terumo, and he received funding from the University of Massachussetts (supported travel with grant from NIH R13) and Children’s Discovery Institute (CDI) from Washington University. Dr. Valentine’s institution received funding from Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute (NHLBI) under award number 1 R13 HD088086-01; the Society for the Advancement of Blood Management (SABM) SABM-Haemonetics Research Starter Grant; and Washington University CDI (CDI-E1-2015–499). Dr. Bateman’s institution received funding from NIH R13 from NICHD/NHLBI and the SABM. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Address requests for reprints to: Jacques Lacroix, MD, Division of Pediatric Critical Care, Department of Pediatrics, Sainte-Justine Hospital, room 3431, 3175 Côte Sainte-Catherine, Montreal (QC), Canada H3T 1C5. E-mail: [email protected]
